Rossari Biotech Ltd
NSE:ROSSARI

Watchlist Manager
Rossari Biotech Ltd Logo
Rossari Biotech Ltd
NSE:ROSSARI
Watchlist
Price: 800 INR 2.48% Market Closed
Market Cap: 44.2B INR
Have any thoughts about
Rossari Biotech Ltd?
Write Note

Income Statement

Earnings Waterfall
Rossari Biotech Ltd

Revenue
19.2B INR
Cost of Revenue
-13.4B INR
Gross Profit
5.8B INR
Operating Expenses
-3.8B INR
Operating Income
2B INR
Other Expenses
-588.2m INR
Net Income
1.4B INR

Income Statement
Rossari Biotech Ltd

Rotate your device to view
Income Statement
Currency: INR
Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
6 031
N/A
6 507
+8%
7 093
+9%
8 310
+17%
10 438
+26%
12 623
+21%
14 830
+17%
16 866
+14%
17 275
+2%
16 883
-2%
16 559
-2%
16 318
-1%
16 898
+4%
17 643
+4%
18 306
+4%
19 096
+4%
19 245
+1%
Gross Profit
Cost of Revenue
(3 744)
(4 108)
(4 622)
(5 582)
(7 495)
(9 312)
(11 050)
(12 559)
(12 583)
(12 092)
(11 713)
(11 499)
(11 909)
(12 415)
(12 935)
(13 449)
(13 429)
Gross Profit
2 287
N/A
2 398
+5%
2 472
+3%
2 728
+10%
2 944
+8%
3 310
+12%
3 779
+14%
4 307
+14%
4 692
+9%
4 792
+2%
4 846
+1%
4 819
-1%
4 989
+4%
5 228
+5%
5 370
+3%
5 647
+5%
5 816
+3%
Operating Income
Operating Expenses
(1 391)
(1 480)
(1 469)
(1 617)
(1 740)
(2 098)
(2 425)
(2 837)
(3 150)
(3 157)
(3 245)
(3 205)
(3 300)
(3 436)
(3 543)
(3 694)
(3 841)
Selling, General & Administrative
(820)
(652)
(1 174)
(462)
(480)
(573)
(1 793)
(799)
(900)
(940)
(2 412)
(996)
(1 030)
(1 049)
(2 824)
(1 072)
(1 122)
Depreciation & Amortization
(184)
(201)
(228)
(253)
(300)
(417)
(481)
(571)
(625)
(606)
(629)
(617)
(612)
(603)
(604)
(616)
(617)
Other Operating Expenses
(387)
(627)
(66)
(901)
(961)
(1 107)
(152)
(1 468)
(1 624)
(1 610)
(204)
(1 592)
(1 658)
(1 784)
(115)
(2 006)
(2 101)
Operating Income
896
N/A
918
+2%
1 002
+9%
1 111
+11%
1 203
+8%
1 213
+1%
1 354
+12%
1 470
+9%
1 542
+5%
1 635
+6%
1 601
-2%
1 613
+1%
1 689
+5%
1 792
+6%
1 827
+2%
1 952
+7%
1 976
+1%
Pre-Tax Income
Interest Income Expense
(5)
(3)
62
(25)
(37)
(66)
68
(149)
(212)
(225)
6
(233)
(202)
(198)
28
(163)
(147)
Non-Reccuring Items
0
0
0
0
0
0
49
0
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
4
0
0
0
6
0
0
0
3
0
0
0
19
0
0
Total Other Income
46
59
0
107
107
163
(115)
97
65
13
(167)
69
75
99
(98)
62
56
Pre-Tax Income
937
N/A
974
+4%
1 068
+10%
1 193
+12%
1 273
+7%
1 309
+3%
1 363
+4%
1 417
+4%
1 395
-2%
1 423
+2%
1 442
+1%
1 450
+1%
1 562
+8%
1 693
+8%
1 776
+5%
1 851
+4%
1 884
+2%
Net Income
Tax Provision
(241)
(244)
(268)
(302)
(327)
(354)
(386)
(399)
(400)
(396)
(370)
(372)
(393)
(437)
(469)
(488)
(497)
Income from Continuing Operations
696
729
800
891
946
955
977
1 018
995
1 027
1 073
1 078
1 168
1 255
1 307
1 364
1 388
Income to Minority Interest
(0)
(1)
2
2
2
2
(0)
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
695
N/A
729
+5%
802
+10%
892
+11%
948
+6%
957
+1%
977
+2%
1 018
+4%
995
-2%
1 027
+3%
1 073
+4%
1 078
+1%
1 168
+8%
1 255
+7%
1 307
+4%
1 364
+4%
1 388
+2%
EPS (Diluted)
13.5
N/A
13.85
+3%
15.47
+12%
16.34
+6%
17.12
+5%
17.28
+1%
17.7
+2%
18.4
+4%
17.98
-2%
18.5
+3%
19.38
+5%
19.47
+0%
21.1
+8%
22.68
+7%
23.62
+4%
24.63
+4%
25.06
+2%

See Also

Discover More